摘要
目的构建真核重组质粒N2ICD/p CMV-Tag4并转染HEK 293T细胞进行表达。方法根据GenBank上Notch2的NICD序列设计引物,采用逆转录聚合酶链反应(RT-PCR)的方法从人宫颈癌细胞Hela细胞扩增人Notch2受体胞内区基因(N2ICD),酶切和测序鉴定后克隆至携带FLAG标签的真核表达载体pCMV-Tag4并进行瞬时和稳定转染HEK 293T细胞,荧光定量PCR(Q-PCR)和蛋白印迹(WB)检测目的蛋白的表达。结果通过RT-PCR克隆获得人N2ICD基因并成功构建重组质粒N2ICD/pCMV-Tag4,目的蛋白N2ICD在HEK 293T细胞中获得表达。结论成功构建稳定表达N2ICD的HEK 293T细胞株,为进一步探讨Notch2受体的功能奠定基础。
Objective To construct a recombinant eukaryotic expression plasmid N2ICD / pCMV-Tag4 and transfect it into HEK 293 T cells. Methods Human Notch2 intracellular domain gene( N2ICD) from Hela cells was amplified by reverse transcription-PCR( RT-PCR) and identified by enzyme restriction,sequencing and blasting and then cloned into eukaryotic expression vector pCMV-Tag4 to construct N2ICD / pCMV-Tag4,which was then transiently and stably transfected into HEK 293 T cells. Quantitative-PCR( Q-PCR) and Western blot was used to detect target protein expression.Results N2ICD was obtained by RT-PCR. The recombinant eukaryotic expression vector Notch2 intracellular domain( N2ICD) /p CMV-Tag4 was successfully constructed and N2ICD was expressed in HEK 293 T cells. Conclusion N2ICD was expressed in HEK 293 T cells,which provides a foundation for further investigating the function of Notch2 receptor.
出处
《中国公共卫生》
CAS
CSCD
北大核心
2016年第3期310-314,共5页
Chinese Journal of Public Health
基金
国家高技术研究发展技术(863计划)(2014AA020909)
国家自然科学基金-广东省联合基金(U1401223)
国家自然科学基金面上项目(81470831)
广东省创新载体建设项目(2013B090800036)